Drug Profile
Immunoglobulin G - Novo Nordisk
Alternative Names: Immunoglobulin intravenous - Novo Nordisk; NordimmunLatest Information Update: 14 Oct 2021
Price :
$50
*
At a glance
- Originator Novo Nordisk
- Class Immunoglobulin isotypes
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Immunodeficiency disorders; Immunological disorders
Most Recent Events
- 16 Oct 1998 Launched for Immunodeficiency disorders in Denmark (IV)
- 16 Oct 1998 Launched for Immunodeficiency disorders in Europe (IV)
- 16 Oct 1998 Launched for Immunodeficiency disorders in Sweden (IV)